Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

9.1K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.1K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

1.7K
1.7K
Site-Targeted Drug Delivery Systems: Polymeric Carriers01:24

Site-Targeted Drug Delivery Systems: Polymeric Carriers

79
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
79
Modified-Release Drug Delivery Systems: Site-Targeted01:24

Modified-Release Drug Delivery Systems: Site-Targeted

70
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
70

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Body mass index and reported contraceptive use prior to the index pregnancy among Chinese women with unintended pregnancy: a multicenter cross-sectional analysis of a prospective cohort.

BMC public health·2026
Same author

Steady-state temperature field of multilayer overlying strata under an equivalent fixed-wall-temperature heat source: similarity experiments and 3D simulation.

Scientific reports·2026
Same author

Metal-Organic Framework-Gated Biocatalysis Enables Triggered Depolymerization of Melt-Processed Polyesters.

Angewandte Chemie (International ed. in English)·2026
Same author

Thermoresponsive Nanoparticles Hijack Neutrophils In Vivo to In Situ Construct Biohybrids for Enhanced Cancer and Infection Therapy.

ACS nano·2026
Same author

Space-Confined Chemical Vapor Deposition of 2D FeS With Crossover Magnetoresistance and Ultra-High Conductivity.

Advanced materials (Deerfield Beach, Fla.)·2026
Same author

Development and Preliminary Mechanistic Evaluation of a Novel Liposomal QS-21 and CpG ODNs Adjuvant System for Enhancing Vaccine Immunogenicity.

Vaccines·2026

Related Experiment Video

Updated: Mar 14, 2026

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?
14:20

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?

Published on: June 13, 2014

17.2K

Biomimetic Cell Membrane-Coated MOFs System for Targeted Cancer Therapy.

Qilu Wu1, Jia Song Deon Chon1, Yuxiao Feng1

  • 1Key Lab for Industrial Biocatalysis, Ministry of Education, Department of Chemical Engineering, Tsinghua University, Beijing, China.

Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|March 12, 2026
PubMed
Summary
This summary is machine-generated.

Cell membrane-camouflaged metal-organic frameworks (MOFs) improve cancer nanomedicine by enhancing tumor targeting and biocompatibility. These biomimetic systems offer advanced drug delivery for better therapeutic outcomes.

Keywords:
biomimiccancer therapycell membranesdrug deliverymetal‐organic frameworks

More Related Videos

Biofunctionalization of Magnetic Nanomaterials
06:40

Biofunctionalization of Magnetic Nanomaterials

Published on: July 16, 2020

3.1K
Author Spotlight: Advances in Evaluating Human Lung Epithelial Cells' Response to Metal-Organic Frameworks
04:53

Author Spotlight: Advances in Evaluating Human Lung Epithelial Cells' Response to Metal-Organic Frameworks

Published on: May 26, 2023

1.8K

Related Experiment Videos

Last Updated: Mar 14, 2026

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?
14:20

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?

Published on: June 13, 2014

17.2K
Biofunctionalization of Magnetic Nanomaterials
06:40

Biofunctionalization of Magnetic Nanomaterials

Published on: July 16, 2020

3.1K
Author Spotlight: Advances in Evaluating Human Lung Epithelial Cells' Response to Metal-Organic Frameworks
04:53

Author Spotlight: Advances in Evaluating Human Lung Epithelial Cells' Response to Metal-Organic Frameworks

Published on: May 26, 2023

1.8K

Area of Science:

  • Biomaterials Science
  • Nanotechnology
  • Cancer Therapeutics

Background:

  • Metal-organic frameworks (MOFs) are promising nanocarriers for drug delivery.
  • Integrating MOFs with cell membranes offers biomimetic advantages for cancer nanomedicine.
  • Cell membrane coating enhances MOF properties like biocompatibility and targeting.

Purpose of the Study:

  • To review recent advances in cell membrane-camouflaged MOFs for cancer drug delivery.
  • To analyze the benefits of these biomimetic systems in tumor targeting, immune evasion, and biocompatibility.
  • To discuss design strategies and future directions in this field.

Main Methods:

  • Systematic review of literature on cell membrane-camouflaged MOFs.
  • Analysis of various cell membrane sources (cancer cells, RBCs, macrophages).
  • Evaluation of hybrid membrane engineering and stimuli-responsive release mechanisms.

Main Results:

  • Cell membrane cloaking improves MOF circulation time and tumor accumulation.
  • Biomimetic MOFs exhibit reduced macrophage uptake, enhancing immune evasion.
  • Different membrane sources offer distinct advantages for tumor homing and immune modulation.

Conclusions:

  • Cell membrane-camouflaged MOFs represent a significant advancement in cancer nanomedicine.
  • Hybrid engineering and stimuli-responsive systems are key design strategies.
  • Future developments should focus on intelligent drug release and personalized combination therapies.